#cannabis research

[time4hemp]

Robert Hoban Takes Time 4 Hemp

Host, Casper Leitch, Joint Host’s, Al Byrne, and Al Graham join guest, Robert Hoban, to take Time 4 Hemp.

The Legal Trailblazer On The War Path

In this compelling audio podcast of Time 4 Hemp, host Casper Leitch, joint host Al Byrne, and technical editor Al Graham sit down with Robert Hoban to discuss his work as a lawyer and a hemp activists.

In the fight to end hemp prohibition and advance the legalization of medical cannabis, few figures have left as profound a mark as Bob Hoban. A pioneering attorney, industry strategist, and policy architect, Hoban has been instrumental in shaping the modern cannabis landscape. His expertise spans legal advocacy, international consulting, and business development, making him a trusted leader among Fortune 1000 companies, government entities, and entrepreneurs in the hemp and marijuana sectors.

Click here to enjoy this interview in video format.

[aos-presents]

In a recent article detailing the study on the neurological effects of THC, by an organization funded by the German government -- found that "long-term, low dose ∆9-THC had an anti-aging effect on the brain, restoring cognitive abilities.

New research published in August 2024, in the American Chemical Society -- Journal of Pharmacology and Science suggested that the results of this recent study demonstrates, a significant positive effect that ∆9-THC treatment against anti-aging in the brain. This is study is closely linked to similar Alzheimer research, where it was found that people who used cannabis for recreational and medical uses, reported less memory loss and confusion, in comparison to non-users.

Follow the link on Twitter for the full article detailing a few research results from various case studies and unbiased fact based reports.

Credit:

[cannaspecialists]

Empower Yourself with ACS Cannabis Education | CannaSpecialists

Discover the future of cannabis with ACS! Our online platform, dedicated to Cannabis Education, offers a wealth of knowledge in Cannabis Research, making you an expert in Cannabinoid Medicine and a valued Cannabis Industry Professional. Join the American Cannabis Society (ACS) and access in-depth insights into the world of cannabis. From the science behind cannabinoids to the latest trends, ACS provides you with the tools to stay ahead.

[brightlotusmoon]

...chronic cannabis users have higher cerebral blood flow and extract more oxygen from brain blood flow than nonusers. The rate at which oxygen is metabolized in the brain was found to be higher in users as well.

While THC is known to relax blood vessels and alter blood flow in the brain, the study focused on how prolonged THC use might affect the brain by analyzing the differences in regional brain blood oxygenation and metabolism in chronic cannabis users.

Due to the prospective nature of the study, published in the journal Neuropsychopharmacology, researchers cannot say whether cannabis use directly causes the observed changes, or whether other underlying conditions also may be at play.

While the reason for the brain changes related to chronic marijuana use is unclear, Filbey said that these changes may reflect underlying differences in brain tissue metabolic rate.

[cannabisbusinessexecutive]

Does using weed make you a nicer person? Results can vary.

Some people may turn to weed for anxiety, sleep and creativity. New research suggests it could also make you a nicer person. The findings, published in the Journal of Neuroscience Research, suggests there could be a connection between cannabis use and empathy. A study of 85 regular cannabis users and 51 nonusers asked participants to complete a test that measures empathy. Researchers also used…

[ghcstcd]

me, looking at the online menu for my favorite dispensary: Ah, yes, a Swiss Roll.

[sanguinifex]

This is huge. As of 8/30/2023, the Federal Department of Health and Human Services wants the DEA to reclassify from schedule 1 (no medical use, completely verboten) to schedule 3 (widely accepted medical use, some abuse potential, similar to Tylenol 3).

It won’t just allow doctors to prescribe it and reduce the penalties for having it if you’re not “supposed to”; it’ll also make it much easier for researchers to do studies with it, giving us health data that is currently lacking. For example, we don’t know much about how THC and CBD affect the liver or liver enzyme levels except in end stage liver disease patients, and what data we do have is decades old and of poor to middling quality.

The expansion of research a Schedule 3 reclassification would allow could pave the way for a safe, non-addictive pain medication based on cannabinoids that works primarily on the CB2 receptors and either doesn’t pass the blood-brain barrier or does cross it but doesn’t cause euphoria or sedation in most patients. In other words, the holy grail of pain medicine. Currently, the only painkiller that utilizes the endocannabinoid system is acetaminophen (Tylenol), which is a weak reuptake inhibitor of anandamide but primarily works via the prostaglandin system, and which is also highly hepatotoxic and somewhat nephrotoxic, and which probably wouldn’t be approved except as prescription fever and pain management, the latter primarily as an adjuvant to opiates, if it were a new drug being reviewed by the FDA today.

This is a really big example of how both parties are not the same. A Republican administration DHHS wouldn’t do this. If the No Fun Allowed Agency follows instructions, this opens up a lot of possibilities for a lot of people. It also completely bypasses the partisan legislatures and courts. Technically it’s easier for a future administration to overturn, but historically the DEA rarely reschedules medications without strong external pressure. (And in this case, it’s already functionally legal for those 21+ in most of the country anyway.)

[time4hemp]

Why Take Time 4 Hemp?

A Deep Dive Into The Time 4 Hemp Network

This segment takes a deep dive into why everyone needs to take Time 4 Hemp. The Deep Dive topic is focused on the work that has grown over the years through the Time 4 Global Hemp Broadcasting Network and explores the type of content that is presented on the website: https://www.Time4Hemp.news

This is the first of, hopefully, many more podcast-cast that is a combination of music and talk. Each segment will feature deep dives into the many different topics that cannabis-hemp is part of - along with amazing songs about:

this versatile plant

or the Freedoms we all treasure;

with a heaping touch of Love

added in for proper measure.

And, every tune, I'm sure

will bring you lots of pleasure.

Along with the Deep Dive Report and cannabis music are a few additional surprises intended to keep the program entertaining and informative.

00:00:00 - Opening - Jet Baker

00:00:40 - Intro - Casper Leitch

00:04:20 - Music: Tree Of Life - The Human Revolution

00:11:37 - PSA - Willie Nelson

00:12:55 - Deep Dive Report - Why Take Time 4 Hemp?

00:37:31 - PSA - Invest In Hemp - CNBC Business Report

00:40:32 - Closing Remarks - Casper Leitch

00:44:38 - PSA - Make Your Life Spectacular - Robin Williams

00:46:19 - Music - Our World - Hemp Street Rhythm

00:51:40 - Closing - Jet Baker

Program Producer and Host: Casper Leitch

Deep Dive Corespondents: Bud Stoner and Juanita Moorehigh

Deep Dive Producer: Albie Inman.

[nycannabistimes]

#Repost @mrhempco ・・・ This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS, this notice publishes: • the decisions made by a delegate1 of the Secretary of the Department of Health and Aged Care (the Delegate) pursuant to regulations 42ZCZR; • the reasons for those final decisions; and • the date of effect of those decisions. ✅ Read the full article ⤵ "𝐋𝐢𝐧𝐤 𝐈𝐧 𝐁𝐢𝐨" 👉 @mrhempco . . . . . . . . . . . #hemp #industrialhemp #agriculture #hempproducts #agricultureaustralia #hempcommunity #australianproducts #australianfashion #hempseed #research #hempproduct #healthylife #australianmade #vegetarianlife #healthylifestyle #cannabis #plantbasedmeals #proteindiet #hempseeds #proteinsources #healthcare #hempcommunity #cannabismedicinal #hempco #mrhempco (at United States of America) https://www.instagram.com/p/Co-Gtk4sBlC/?igshid=NGJjMDIxMWI=

[cannaspecialists]

Explore Comprehensive Cannabis Education at Canna Specialists

At Canna Specialists, we offer a wealth of resources for those seeking to expand their knowledge in cannabis education, research, and industry expertise. Whether you're a seasoned Cannabis Industry Professional, interested in Cannabinoid Medicine, or part of the American Cannabis Society, our platform provides valuable insights and educational materials. Explore the latest trends, research, and developments in the cannabis field. Join us on a journey of discovery, and empower yourself with the knowledge and expertise needed to thrive in the world of cannabis.

[brightlotusmoon]

Marijuana Users Have More Empathy And A Greater Understanding Of Other People's Emotions, Study Finds

Researchers said the results suggest a potential association between cannabis use and empathy, though they caution that further research is needed to fully understand the interactions “since many other factors may be at play.”

In attempting to explain the findings, the team of neuroscientists noted that a part of the brain, the anterior cingulate cortex (ACC), “is a region that is prone to the effects of cannabis consumption and is also greatly involved in empathy, which is a multi-component process that can be influenced in different ways.”

“Given that the ACC is one of the main areas that possess CB1 [cannabinoid] receptors and is heavily involved in the representation of the affective state of others,” the study says, “we believe that the differences shown by regular cannabis users in the emotional comprehension scores and their brain functional connectivity could be related to the use of cannabis.”

Despite the qualifiers, the study concludes, “Given previous studies of the effect of cannabis on mood and emotional detection, we believe that these results contribute to open a pathway to study further the clinical applications of the positive effect that cannabis or cannabis components could have in affect and social interactions.”

In other neuroscience research this year, researchers at the University of West Attica in Greece found that medical marijuana use was associated with improved quality of life — including better job performance, sleep, appetite, and energy — among people with neurological disorders.

Another recent study published by the American Medical Association found that medical marijuana was associated with “significant improvements” in quality of life for people with conditions like chronic pain and insomnia—and those effects were “largely sustained” over time.

Other studies have found cannabis may boost the “runner's high” felt during exercise and enhance the practice of yoga.

[alyfoxxxen]

Largest Study Ever Done on Cannabis and Brain Function Finds Impact on Working Memory

[kazifatagar]

Ex-research assistant Yusoff Rawther pleads not guilty to cannabis trafficking charges

KUALA LUMPUR, Dec 6 — Muhammed Yusoff Rawther, 31, a former research assistant to a politician, pleaded not guilty in the High Court to trafficking 305 grams of cannabis on September 6. The charge, under Section 39B(1)(a) of the Dangerous Drugs Act 1952, carries a mandatory life sentence and at least 12 lashes if convicted. The alleged offence occurred at the Kuala Lumpur Contingent Police…

[cannabisbusinessexecutive]

About That ‘Cannabis Causes Head and Neck Cancer’ Study

The news that a just-released study has revealed a connection between daily cannabis use and head and neck cancers was so irresistible that pretty much every media outlet whether cannabis-related or not was literally compelled to run with it, just as CNN did, and breathlessly herald the fatal results in a head-turning headline: Daily marijuana use linked to increased risk of deadly head and neck…

[trendtrackershq]

The Cannabis Market in Europe: An Emerging Powerhouse

Introduction

The cannabis market in Europe is experiencing unprecedented growth, positioning the region as a dominant player in the global cannabis industry. This surge is driven by changing regulatory landscapes, increasing acceptance of cannabis for medicinal and recreational purposes, and significant investments in research and development. As Europe navigates this transformative period, it stands poised to become a central hub for cannabis innovation and commercialization.

Download Free Sample: https://www.nextmsc.com/cannabis-market/request-sample

Regulatory Landscape

The regulatory environment in Europe is a complex mosaic, with each country adopting its own stance on cannabis legalization. Countries like Germany, Italy, and the Netherlands are leading the charge, having established comprehensive frameworks for medicinal cannabis. Germany, in particular, has set a benchmark with its progressive policies, making it the largest medicinal cannabis market in Europe. The country's robust healthcare system and insurance coverage for medicinal cannabis have significantly contributed to this growth.

Italy has also made strides in the medicinal cannabis sector, with the Ministry of Health overseeing the production and distribution of cannabis for therapeutic use. The Netherlands, known for its liberal approach, continues to be a pioneer with its well-established cannabis coffee shops and medical cannabis programs.

Market Dynamics

The European cannabis market is characterized by its rapid expansion and evolving consumer base. According to recent reports, the European cannabis market is projected to reach €3.2 billion by 2025, driven by both medicinal and recreational segments.

One of the key drivers of this growth is the increasing recognition of cannabis's therapeutic potential. Conditions such as chronic pain, multiple sclerosis, and epilepsy are being effectively managed with cannabis-based treatments, leading to higher demand for medicinal cannabis products. Additionally, the aging population in Europe, which is more susceptible to chronic illnesses, is contributing to the market's

Regulatory Landscape

The regulatory environment in Europe is a complex mosaic, with each country adopting its own stance on cannabis legalization. Countries like Germany, Italy, and the Netherlands are leading the charge, having established comprehensive frameworks for medicinal cannabis. Germany, in particular, has set a benchmark with its progressive policies, making it the largest medicinal cannabis market in Europe. The country's robust healthcare system and insurance coverage for medicinal cannabis treatments have created a strong demand for cannabis products.

In Italy, the use of medicinal cannabis is also well-regulated, with a focus on treating chronic pain, multiple sclerosis, and other conditions. The Netherlands, known for its liberal approach, has long been a pioneer in cannabis policy, allowing the use of cannabis for medicinal and recreational purposes under regulated conditions. Other countries, such as Portugal, Spain, and Denmark, are also making significant strides in legalizing and regulating cannabis for medicinal use, creating a ripple effect across the continent.

Market Growth Drivers

Increasing Medicinal Cannabis Use: One of the primary drivers of the cannabis market in Europe is the rising acceptance and use of cannabis for medicinal purposes. With an aging population and an increasing prevalence of chronic diseases, there is a growing demand for alternative treatments. Medicinal cannabis is being used to manage a range of conditions, including chronic pain, epilepsy, cancer-related symptoms, and mental health disorders.

Shifting Public Perception: Public perception of cannabis is gradually changing, with more people recognizing its potential benefits. This shift is partly due to extensive research and awareness campaigns highlighting the therapeutic effects of cannabis. As stigma diminishes, more individuals are open to exploring cannabis-based treatments.

Investment in Research and Development: Significant investments in research and development are fueling innovations in the cannabis sector. European companies are at the forefront of developing new cannabis strains, extraction methods, and delivery systems. This focus on R&D is not only improving product quality but also expanding the range of available cannabis-based treatments.

Economic Opportunities: The economic potential of the cannabis market is attracting investors and entrepreneurs. The sector is creating jobs, boosting local economies, and generating substantial tax revenues. Countries are recognizing the economic benefits of a regulated cannabis market, which is driving legislative changes.

Key Players and Market Dynamics

Europe's cannabis market is characterized by a dynamic and competitive landscape, with several key players leading the charge. Companies like Aurora Cannabis, Canopy Growth, and Tilray have established a strong presence in Europe through strategic partnerships and acquisitions. These companies are leveraging their expertise and resources to expand their market share and introduce innovative products.

Local players are also making significant contributions. For instance, German-based Aphria RX GmbH is one of the leading suppliers of medicinal cannabis in the country. Bedrocan, a Dutch company, is known for its standardized cannabis products, which are used in clinical research and patient care across Europe. These companies are focused on quality, consistency, and patient safety, which are crucial for gaining trust in the medicinal cannabis market.

Inquire Before Buying: https://www.nextmsc.com/cannabis-market/inquire-before-buying

Challenges and Opportunities

While the cannabis market in Europe is burgeoning, it faces several challenges. The fragmented regulatory environment can be a hurdle for companies operating across multiple countries. Navigating the different laws and regulations requires significant resources and expertise. Additionally, there are concerns about product quality and safety, which necessitate stringent testing and standardization.

However, these challenges also present opportunities. Companies that can navigate the regulatory landscape effectively and ensure high-quality products stand to gain a competitive edge. The growing acceptance of cannabis for medicinal use is also opening up new avenues for research and product development. For instance, there is increasing interest in developing cannabis-based pharmaceuticals and wellness products.

Future Outlook

The future of the cannabis market in Europe looks promising. With ongoing legislative changes, increasing investment in research, and growing public acceptance, the market is poised for significant expansion. The trend towards legalization and regulation is likely to continue, creating a more conducive environment for business growth and innovation.

Germany is expected to remain a key market, with potential reforms that could further liberalize cannabis use. Other countries, such as France and the United Kingdom, may also see significant developments as public opinion shifts and the economic benefits of cannabis legalization become more apparent.

Moreover, the focus on sustainability and organic cultivation practices is likely to shape the future of the cannabis industry in Europe. Consumers are increasingly looking for products that are not only effective but also ethically and sustainably produced. This trend could drive the adoption of eco-friendly cultivation methods and the development of organic cannabis products.

Conclusion

Europe's cannabis market is at a pivotal moment, with the region emerging as a dominant player on the global stage. The convergence of favorable regulatory changes, increasing medicinal use, and significant investment in research and development is driving robust market growth. As countries continue to embrace cannabis for its therapeutic potential and economic benefits, Europe is set to become a central hub for cannabis innovation and commercialization. The road ahead is filled with opportunities for companies that can navigate the complexities of the market and deliver high-quality, safe, and effective cannabis products.